Skip to content

The pleiotropic metabolic effects of bariatric surgery

The pleiotropic metabolic effects of bariatric surgery - Bariatric surgery and Metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33590
Enrollment
30
Registered
2008-08-18
Start date
2008-09-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesitas/hypertensie/glucose en lipiden metabolisme metabolic syndrome

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: pre-menopausal Caucasian women scheduled for Roux-en-Y gastric bypass surgery

Exclusion criteria

Exclusion criteria: any chronical medical condition except for glucose intolerance, hypertension and secondary dyslipidemia use of medication which interferes with dopamine metabolism clinically overt atherosclerotic events claustrophobia and unremovable metal objects tobacco use (i.e. smokers) malignant or uncontrolled hypertension (blood pressure >200/120 mmHg or blood pressure >180/110 mmHg with 1 or more drugs, or >160/100 with 2 or more drugs) unwilling or unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
- hypothalamic dopamine receptor binding capacity - insulin sensitivity - inflammatory changes in adipose tissue and liver

Secondary

MeasureTime frame
- bloodpressure and sympathetic activity - hypothalamic activity (measured with functional MRI) - phenotypical differences (adipose tissue distribution, plasma parameters)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)